KSE - Delayed Quote KRW

SK bioscience Co.,Ltd. (302440.KS)

40,200.00
+200.00
+(0.50%)
At close: 3:30:22 PM GMT+9
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-128,019,868.86
-128,019,868.86
29,346,360.89
-124,958,284.38
536,593,687.78
Investing Cash Flow
53,563,803.18
53,563,803.18
-45,278,721.20
272,646,504.51
-1,421,940,285.27
Financing Cash Flow
252,479,228.09
252,479,228.09
-89,582,616.43
-19,867,162.02
958,380,286.59
End Cash Position
312,701,506.49
312,701,506.49
127,025,638.85
225,287,448.49
98,028,261.47
Capital Expenditure
-172,224,779.94
-172,224,779.94
-50,295,489.14
-76,489,443.39
-44,469,559.63
Issuance of Capital Stock
75,680,234.21
75,680,234.21
397,598.91
2,617,945.59
983,255,829.46
Issuance of Debt
192,056,903.92
192,056,903.92
1,000,000
48,741,669.88
11,323,630.88
Repayment of Debt
--
--
-84,553,994.27
-64,195,557.18
-33,734,000
Free Cash Flow
-300,244,648.80
-300,244,648.80
-20,949,128.25
-201,447,727.77
492,124,128.15
12/31/2021 - 3/18/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers